| Name | Title | Contact Details |
|---|---|---|
Bryan Garabrandt |
Chief Technologist | Profile |
AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A New Drug Application (NDA) was filed with the FDA in December 2016. ZALVISO is designed to deliver sublingual tablets containing 15 mcg sufentanil via a novel hand-held, pre-programmed, patient-controlled analgesia system. Three Phase 3 clinical trials have been completed in patients who had undergone major abdominal or orthopedic surgeries. A fourth study (IAP312) is underway to further evaluate the overall performance of the ZALVISO System in post-surgical patients. ZALVISO is currently approved by the European Commission for the management of acute moderate-to-severe post-operative pain in adult patients in a hospital setting, and is marketed by Grünenthal Group, AcelRx`s licensee in Europe and Australia. In the United States and other geographies, ZALVISO remains an investigational product.
Centric Health`s vision is to be Canada`s premier healthcare company, providing innovative solutions centered on patients and healthcare professionals.
High-performing pharmacy is who we are At Visante, we believe in moving healthcare forward through innovative solutions that deliver lasting results. For over 20 years, we`ve been advancing the business of pharmacy™ by helping our clients deliver compliant services and products that foster growth and improve patient care. Our firm focuses on three areas of medication management: hospitals and health systems, pharmaceutical industry and managed care/government programs. Integrated health networks (IDNs), hospitals and health systems know us for our expertise to maximize lasting growth in 340B programs, specialty pharmacy, pharmacy assessments, sterile compounding and drug diversion. In addition, through our partner PharmacyStars, we provide a platform of technology solutions for our hospital and health system clients to maximize compliance in the areas of 340B, sterile compounding, drug diversion and more. Our managed care and government programs experts are here to help you navigate complex, changing requirements to reach compliance goals. Specializing in Medicare Parts C and D consulting, we can help you prepare for audits by the Centers for Medicare and Medicaid Services (CMS), conduct mock audits, improve operations, and maintain compliance. No matter how complex your compliance issues and operational needs are, we`re here to implement quality, cost-effective solutions. Visante consists of more than 60 consultants across the U.S., Canada, and the U.K., all working together to provide expert guidance from a wide range of disciplines, including pharmacy, nursing, operations, and information technology. We`re here to move the practice of pharmacy in the right direction.
Innovative Product Achievements, LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Duluth, GA. To find more information about Innovative Product Achievements, LLC, please visit www.thinkipa.com
Lafayette General Health is Acadianas largest non-profit, community-owned regional health system committed to always delivering excellence. The system has over 4,000 employees, serving the south-central region of Louisiana by aligning with facilities across Acadiana. Lafayette General Health is a founding member of the Ochsner Health Network.